The authors of these reports frequently have financial ties to clinics promoting BPC-157, casting doubt on the objectivity of their findings
Moreover, in terms of reduction in hemoglobin A1c (HbA1c) levels, the 50 mg dose of oral semaglutide outperformed the 14 mg dose, with reductions of 2.1% and 1.3%, respectively, at 68 weeks
At Pure Medical Spa, we provide comprehensive weight loss programs, combining medication, lifestyle guidance, and ongoing support to help you reach your goals safely
Animal studies have shown concerns like reduced fetal growth, developmental abnormalities, and pregnancy loss at doses similar to those used in humans
The Endocrine Society's 2023 clinical practice guidelines on obesity pharmacotherapy note that "the absence of safety data in humans should not be conflated with a safety guarantee, particularly when preclinical mechanisms suggest CNS activity" [11]